"The Company achieved the Q4 results despite ~$287K foreign exchange losses and ~$123K
capital growth spending on components for product manufacture and sale in FY 2021."
Seems strange they would say that considering they usually spend more than that on "product manufacturing and operating costs"? Also not a great sign of confidence in demand over the next quarters with reduced spending on components compared to last year.
- Forums
- ASX - By Stock
- UCM
- Ann: Appendix 4C - quarterly
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: Appendix 4C - quarterly, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 132270 | 0.012 |
1 | 100000 | 0.010 |
1 | 150000 | 0.008 |
2 | 2000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online